期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Management of nocturnal enuresis-myths and facts 被引量:18
1
作者 Rajiv Sinha sumantra raut 《World Journal of Nephrology》 2016年第4期328-338,共11页
Nocturnal enuresis often causes considerable distress or functional impairment to patient and their parents necessitating a multidisciplinary approach from paediatrician, paediatric nephrologist, urologists and psychi... Nocturnal enuresis often causes considerable distress or functional impairment to patient and their parents necessitating a multidisciplinary approach from paediatrician, paediatric nephrologist, urologists and psychiatrist. Mechanisms of monosymptomatic nocturnal enuresis are mainly nocturnal polyuria, bladder overactivity and failure to awaken from sleep in response to bladder sensations. Goal oriented and etiology wise treatment includes simple behavioral intervention, conditioning alarm regimen and pharmacotherapy with desmopressin, imipramine and anticholinergic drugs. Symptoms often recurs requiring change over or combination of different modes of treatment. 展开更多
关键词 Nocturnal enuresis Monosymptomatic Conditioning alarm DESMOPRESSIN IMIPRAMINE
下载PDF
Pediatric lupus nephritis: Management update 被引量:4
2
作者 Rajiv Sinha sumantra raut 《World Journal of Nephrology》 2014年第2期16-23,共8页
Childhood-onset systemic lupus erythematosus (cSLE) is a severe multisystem autoimmune disease. Renal involvement occurs in the majority of cSLE patients and is often fatal. Renal biopsy is an important investigatio... Childhood-onset systemic lupus erythematosus (cSLE) is a severe multisystem autoimmune disease. Renal involvement occurs in the majority of cSLE patients and is often fatal. Renal biopsy is an important investigation in the management of lupus nephritis. Treatment of renal lupus consists of an induction phase and main-tenance phase. Treatment of childhood lupus nephritis using steroids is associated with poor outcome and excess side-effects. The addition of cyclophosphamide to the treatment schedule has improved disease control. In view of treatment failure using these drugs and a tendency for non-adherence, many newer agents such as immune-modulators and monoclonal antibodies are being tried in patients with cSLE. Trials of these novel agents in the pediatric population are still lacking making a consensus in the management protocol of pediatric lupus nephritis diffcult. 展开更多
关键词 PEDIATRIC Lupus nephritis MANAGEMENT Monoclonal antibody CYCLOPHOSPHAMIDE Mycophenolate mofetil
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部